The vagina as source and target of androgens: implications for treatment of GSM/VVA, including DHEA.

Cipriani, S; Maseroli, E; Ravelli, S A; Vignozzi, L

Cipriani, S; Maseroli, E; Ravelli, S A; Vignozzi, L.

Afiliación

Cipriani S; Andrology, Women's Endocrinology and Gender Incongruence Unit, Careggi University Hospital, Florence, Italy.
Maseroli E; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.
Ravelli SA; Andrology, Women's Endocrinology and Gender Incongruence Unit, Careggi University Hospital, Florence, Italy.
Vignozzi L; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.

Climacteric ; 26(4): 309-315, 2023 08.

Article en En | MEDLINE | ID: mdl-37288964

Asunto(s)

Andrógenos; Dispareunia; Femenino; Humanos; Andrógenos/uso terapéutico; Deshidroepiandrosterona/uso terapéutico; Dispareunia/tratamiento farmacológico; Administración Intravaginal; Vagina/patología; Menopausia; Estrógenos/uso terapéutico; Atrofia

Palabras clave

Genitourinary syndrome of menopause; androgens in women; dehydroepiandrosterone; female sexual dysfunction; intracrinology; prasterone; vagina; vulvovaginal atrophy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dispareunia / Andrógenos Límite: Female / Humans Idioma: En Revista: Climacteric Asunto de la revista: GINECOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google